Skip to NavigationSkip to content

News

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into the benefit of the...
Novartis has revealed that its proposed label expansion for CAR T therapy Kymriah has been accepted under accelerated regulatory pathways on both...
Engineers at the University of Connecticut have developed a biodegradable pressure sensor which is designed to, once ingested, aid in the detection...
Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 billion, and it is...
When Peter Gassner, CEO and founder of Veeva, provided the keynote speech at the company’s European Commercial & Medical Summit, he captured a...
MSD has stepped up the plate and revealed its immunotherapy combination trial results, and they're enough to send the company's shares soaring and...
The FDA has expanded the indication of Boehringer's Gilotrif to include the first-line treatment of patients with metastatic NSCLC whose tumours...
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on behalf of...
Novartis has lifted the curtain on new data comparing the efficacy of Cosentyx (secukinumab) to Janssen’s Stelara (ustekinumab) in achieving skin...
Teva's Trisenox (arsenic trioxide) injection has been awarded US approval from the FDA in combination with tretinoin for the treatment of newly-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches